Opthea, with shares still suspended, cuts workforce by 65% after drug trials cancelled
Troubled biotech stock Opthea (ASX:OPT), still in the process of crisis talks…
Opthea Limited (ASX:OPT)
About Opthea Limited
Key Information
OPT In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 10/04/2025 | Price Sensitive PS Opthea Provides Corporate Update | 485.05KB | 14K |
| 31/03/2025 | Price Sensitive PS Continuation of Suspension from Quotation | 109.5KB | 3.5K |
| 31/03/2025 | Price Sensitive PS Opthea Announces Decision to Discontinue Wet AMD Trials | 491.5KB | 62K |
| 31/03/2025 | Becoming a substantial holder | 1003.58KB | 3K |
| 25/03/2025 | Ceasing to be a substantial holder | 742.32KB | 2.5K |
| 24/03/2025 | Price Sensitive PS Opthea Announces COAST Phase 3 Trial Topline Results | 520.92KB | 210K |
| 19/03/2025 | Price Sensitive PS Voluntary suspension | 1.07MB | 220K |
| 17/03/2025 | Price Sensitive PS Trading Halt | 767.42KB | 99K |